HLS Cash Flow Statement

Click line-items for a historical chart and %
Cash flows from operating activities:
Net income 235.9M
Income from discontinued operations -4.5M
Adjustments to reconcile net income to net cash provided by operating activities-
Provision for doubtful accounts 27M
Provision for government, class action, and related settlements
Depreciation and amortization 82.5M
(Gain) loss on interest rate swaps 0
Loss on early extinguishment of debt 4M
Equity in net income of nonconsolidated affiliates -12.7M
Distributions from nonconsolidated affiliates 11M
Stock-based compensation 24.1M
Deferred tax expense 102.7M
Other
(Increase) decrease in assets-
Accounts receivable -51.3M
Other assets
Income tax refund receivable
Increase (decrease) in liabilities-
Accounts payable -4.4M
Accrued interest 3.4M
Other liabilities 100K
Premium received on bond issuance
Premium paid on redemption of bonds
Refunds due patients and other third-party payors 2.7M
Government, class action, and related settlements 2.6M
Net cash provided by operating activities of discontinued operations 2M
Total adjustments 180.1M
Net cash provided by operating activities 411.5M
Cash flows from investing activities:
Capital expenditures -140.8M
Acquisition of a business, net of cash acquired -3.1M
Purchase of restricted investments -9.1M
Proceeds from sale of restricted investments 300K
Net change in restricted cash -14M
Net settlements on interest rate swaps
Other -900K
Net cash (used in) provided by investing activities of discontinued operations
Net cash used in investing activities -178.8M
Cash flows from financing activities:
Principal borrowings on term loan 0
Proceeds from bond issuance 275M
Principal payments on debt, including pre-payments -166.2M
Borrowings on revolving credit facility 135M
Payments on revolving credit facility -245M
Principal payments under capital lease obligations -12.1M
Debt issue costs
Dividends paid on convertible perpetual preferred stock -24.6M
Distributions paid to noncontrolling interests of consolidated affiliates -49.3M
Other 400K
Net cash used in financing activities -130M
Increase in cash and cash equivalents 102.7M
Cash and cash equivalents at beginning of period 30.1M
Less: Cash and cash equivalents of facilities held for sale at end of period
Cash and cash equivalents at end of period 132.8M

Entities mentioned with HLS

View All Entities